← Back to headlines
Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal
Insilico Medicine and SK Biopharmaceuticals have announced a $2.5 billion deal focused on AI drug discovery, specifically targeting neuroimmune therapies.
22 Jun, 21:00 — 22 Jun, 21:00
Sources
Showing 1 of 1 sources
Related Stories
Apple Unveils Foldable iPhone Duo and New AI Strategy at 2026 Event
37m ago
Google Commits $15 Billion to AI Infrastructure and Nuclear Power in Finland
51m ago
Apple Unveils First Foldable iPhone Duo and New AI Features
1h ago
White House Removes 'Build the Wall' Game After Tetris Copyright Complaint
2h ago